Cognitive & Neuroprotection
Galantide

Last updated
Dosing on file unverified
TBD (no human dosing)
Carried from a source that labels it unverified, and reproduced with that label attached. A record of what is reported, not a recommendation. No citation on this page establishes it.
Literature on file 6
-
animal in vivo
Galantide stimulates sexual behavior in male rats (1994, cited 25x) graded on: an animal model — “rats”
-
animal in vivo
Galanin plays a role in antinociception via binding to galanin receptors in the nucleus accumbens of rats with neuropathic pain. graded on: an animal model — “rats”
-
animal in vivo
Involvements of galanin and its receptors in antinociception in nucleus accumbens of rats with inflammatory pain. graded on: an animal model — “rats”
-
in vitro
Galanin and galanin-like peptide modulate vasopressin and oxytocin release in vitro: the role of galanin receptors. graded on: an in-vitro system — “in vitro”
-
animal in vivo
The combination of neurokinin-1 and galanin receptor antagonists ameliorates caerulein-induced acute pancreatitis in mice. graded on: an animal model — “mice”
Not graded
1 citation whose study design could not be read from the title. Left ungraded rather than guessed at.
- not graded
Identity
Skeletal formulathe canonical depiction
Drawn by PubChem from CID 16132126, the identifier on this record.
- Molecular weight
- 2199.5
- Molecular formula
- C104H151N25O26S
- CAS number
- 138579-66-5
- PubChem CID
- 16132126
- InChI key
- TZOJVPDIYKRJSM-GKPUQKAJSA-N
- SMILES
- C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N2CCC[C@H]2C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N)NC(=O)[C@H](CC5=CNC6=CC=CC=C65)NC(=O)CN)O
- InChI
- InChI=1S/C104H151N25O26S/c1-54(2)39-70(91(142)113-52-87(139)129-37-20-27-80(129)103(154)120-69(33-35-82(107)134)93(144)119-68(32-34-81(106)133)94(145)124-76(44-61-23-16-13-17-24-61)99(150)123-74(43-60-21-14-12-15-22-60)92(143)112-51-86(138)116-71(40-55(3)4)95(146)118-67(89(109)140)36-38-156-11)121-96(147)72(41-56(5)6)122-98(149)75(45-62-28-30-64(132)31-29-62)117-85(137)50-111-90(141)58(9)114-102(153)79(53-130)127-100(151)78(47-83(108)135)125-97(148)73(42-57(7)8)126-104(155)88(59(10)131)128-101(152)77(115-84(136)48-105)46-63-49-110-66-26-19-18-25-65(63)66/h12-19,21-26,28-31,49,54-59,67-80,88,110,130-132H,20,27,32-48,50-53,105H2,1-11H3,(H2,106,133)(H2,107,134)(H2,108,135)(H2,109,140)(H,111,141)(H,112,143)(H,113,142)(H,114,153)(H,115,136)(H,116,138)(H,117,137)(H,118,146)(H,119,144)(H,120,154)(H,121,147)(H,122,149)(H,123,150)(H,124,145)(H,125,148)(H,126,155)(H,127,151)(H,128,152)/t58-,59+,67-,68-,69-,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,88-/m0/s1
Notes unverified prose
Synthetic galanin antagonist for research only; not intended for human clinical or medical purposes; no human trials identified; No human clinical trials; research only
Not on file 1
1 of the 8 fields we track hold nothing on this record, and each says why. A blank field is a bug; a named absence is a finding.
- amino-acid sequencenothing we hold supplies it
Each field links to every other record missing the same thing. The full ledger holds 521 gaps across 136 records.